Codexis, Inc. - Common Stock (NQ:CDXS)

1.492 +0.022 (+1.49%)

Streaming Delayed Price Updated: 10:56 AM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codexis, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Codexis: Q2 Earnings Insights ↗

August 04, 2022

Codexis (NASDAQ:CDXS) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Codexis beat estimated earnings by...

Via Benzinga

US Stock Futures Higher Ahead of J&J, Netflix Earnings ↗

July 19, 2022

Pre-open movers

Via Benzinga

Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday ↗

July 19, 2022

With US stock futures trading higher this morning on Tuesday ahead of earnings reports from several companies, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Codexis Shares Slide On CEO Transition ↗

July 18, 2022

Via Benzinga

Crude Oil Rises By More Than 2%; Codexis Shares Plummet ↗

July 15, 2022

U.S. stocks traded higher toward the end of trading, following the release of several earnings results and economic reports.

Via Benzinga

Why Codexis Shares Are Slumping Today ↗

July 15, 2022

Via Benzinga

Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday ↗

July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 15, 2022

Via Benzinga

Dow Jumps More Than 600 Points; Citigroup Tops Q2 Expectations ↗

July 15, 2022

U.S. stocks traded higher midway through trading, following the release of several earnings results and economic reports.

Via Benzinga

Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session ↗

July 15, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.

Via Benzinga

Why U.S. Stocks Are Trading Higher; Retail Sales Rise This Much In June ↗

July 15, 2022

U.S. stocks traded higher this morning, following the release of several earnings results and economic reports.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 15, 2022

Good morning! We're starting the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on...

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 22, 2022

Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle...

Via Benzinga

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

April 21, 2022

From seqWell

Via Business Wire

Codexis: Q4 Earnings Insights ↗

February 24, 2022

Codexis (NASDAQ:CDXS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Codexis...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

3 Synthetic Biology Stocks In Focus With Strong Potential ↗

December 26, 2021

Here we discuss three stocks engaged in the field of scientific biology that investors must follow, as they have the potential to generate wealth going forward.

Via Talk Markets

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Top Biotech Stocks: Trading Opportunities For Next Week ↗

December 19, 2021

A security pattern traces the distinct movements of prices, which helps traders make informed trading decisions. Let's look at some biotech stock opportunities by analyzing these patterns.

Via Talk Markets

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

64 Stocks Moving In Friday's Mid-Day Session ↗

November 05, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 05, 2021

Gainers Ontrak (NASDAQ:OTRK) shares rose 21.82% to $11.78 during Friday's pre-market session. The market value of their outstanding shares is at $225.5 million. As per...

Via Benzinga

Codexis Inc (CDXS) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

CDXS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Up Over 500% in the Last 5 Years, Can This Biotech Continue Its Hot Streak? ↗

October 20, 2021

Codexis is leveraging its core technology to create more effective life science tools.

Via The Motley Fool

Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin ↗

September 10, 2021

Codexis Inc (NASDAQ: CDXS) has amended and extended its agreement with Merck & Co Inc (NYSE: MRK) to license and supply a proprietary enzyme used to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 09, 2021

Gainers IVERIC bio (NASDAQ:ISEE) shares ...

Via Benzinga

Return on Capital Employed Insights for Codexis ↗

August 31, 2021

After pulling data from Benzinga Pro it seems like during Q2, Codexis's (NASDAQ:CDXS) reported sales totaled $25.45 million. Despite a 51.0% in earnings, the company posted a loss...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.